Hepatitis B vaccination and control of Hepatitis B-related liver disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 31, Issue SUPPL. 2, 2000, Pages 112-117

  Chang, M H ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

CHRONIC HEPATITIS; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VACCINATION;

CARCINOMA, HEPATOCELLULAR; CHILD; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; IMMUNIZATION; LIVER DISEASES; LIVER NEOPLASMS;

HEPATITIS B VIRUS;

EID: 0033868615     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200008000-00005     Document Type: Review

References (41)

1. Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal
2. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: A study just before mass hepatitis B vaccination program in Taiwan
3. Vertical transmission of hepatitis B antigen in Taiwan
4. Horizontal transmission of hepatitis B virus in children
5. Injections given in healthcare settings as a major source of acute hepatitis B in Moldova
6. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis
7. Nucleotide sequence analysis of the precore region in patients
8. Precore mutant of hepatitis B virus in childhood fulminant hepatitis B: An infrequent association
9. Prospective study of asymptomatic HBsAg carrier children infected in the perinatal period: Clinical and liver histologic studies
10. Dane particle-associated DNA polymerase and e antigen: Relation to chronic hepatitis among carriers of hepatitis B surface antigen
11. The significance of spontaneous hepatitis B antigen seroconversion in childhood: With special emphasis on the clearance of hepatitis B e antigen before three years of age
12. Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children
13. Long-term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion
14. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood
15. Long-term evolution of chronic hepatitis B in children with antibody to hepatitis B e antigen
16. Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma
17. Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection
18. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 32,707 men in Taiwan
19. Association of hepatitis B surface (Hbs) antigenemia and membranous nephropathy in children in Taiwan
20. Chronic viral hepatitis and the human genome
21. Incidence of hepatitis B virus infection in preschool children in Taiwan
22. Incidence of hepatitis among students at a university in Taiwan
23. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia
24. HLA and hepatitis B infection
25. Cellular immune response to hepatitis B core antigen in maternal-infant transmission of hepatitis B virus
26. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state
27. Immunogenicity of hepatitis B virus vaccine in healthy Chinese neonates
28. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine
29. Long-term immune response of universal hepatitis B vaccination in infancy: A community-based study in Taiwan
30. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen
31. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers
32. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan
33. Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand
34. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages
35. Hepatitis B vaccination: Universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field
36. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
37. Outcome of newborns with hepatitis B surface antigenemia at birth
38. Effect of hepatitis B virus mutants on efficacy of vaccination
39. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan
40. Hepatitis B vaccine and central nervous system demyelinating diseases
41. Global status of hepatitis B immunization